glp-1 review article receptor agonists and cardiovascular outcome trials: An update Glucagon-like peptide-1 receptor: mechanisms and

The primary outcome is simple but meaningful: How many heavy drinking days per week they have at the end of the study compared to when they started. Secondary outcomes include changes in WHO risk categories and levels of phosphatidylethanol, a blood biomarker for alcohol use

Always label the vial with the date of reconstitution and the final concentration (e.g., "Retatrutide 10 mg/mL, Reconstituted on [Date]")

Youth Risk Behavior Survey Data Summary & Trends Report: 20092019

5 listener questions on SubQ insulin, peripheral vasopressin, calcium in Afib, bougie safety, and dirty epi drips are your topics ripped from the mailbag this week, and Swami and Scott are tearing through them in this fast-paced 2-part segment

One recent randomized control trial split participants into an exercise group, a GLP-1 group, and a combined group (7)